Exit Interviews Exploring Patients' Experience of Changes in Their Fatigue During the Phase 3 Clinical Trial of Mirikizumab for Treatment of Moderately to Severely Active Crohn's Disease

被引：0
|
作者：
Gibble, Theresa [1 ]
Macey, Jake [2 ]
Makin, Harriet [2 ]
Rosu, Rodica [1 ]
Mellor, Katie [2 ]
Kitchen, Helen [2 ]
Hon, Emily [1 ]
Vadhariya, Aisha [1 ]
Su, Sylvia [1 ]
Regueiro, Miguel D. [3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
[2] Clarivate, Clin Outcomes Assessment, London, England
[3] Cleveland Clin, Cleveland, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034904.32982.54
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1384
引用
收藏
页码：S989 / S990
页数：2
相关论文
共 50 条
  • [1] Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's Disease
    Hunter Gibble, Theresa
    Macey, Jake
    Makin, Harriet
    Rosu, Rodica
    Mellor, Katie
    Kitchen, Helen
    Hon, Emily
    Dubinsky, Marla
    CROHNS & COLITIS 360, 2025, 7 (01)
  • [2] Exit interviews exploring Crohn's disease patients' experience of changes in their bowel urgency during the mirikizumab Phase 3 clinical trial in adult patients with moderate to severe Crohn disease
    Gibble, T. H.
    Macey, J.
    Makin, H.
    Rosu, R.
    Mellor, K.
    Kitchen, H.
    Carlier, H.
    Dubinsky, M. C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1343 - I1344
  • [3] Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn's Disease: Results from a phase 3 clinical trial
    Travis, S.
    Hisamatsu, T.
    Fischer, M.
    Dubinsky, M.
    Jairath, V.
    Chen, M.
    Ferrante, M.
    Peyrin-Biroulet, L.
    Siegmund, B.
    Gibble, T. Hunter
    Lin, Z.
    Protic, M.
    Morris, N.
    Ghosh, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I21 - I23
  • [4] Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn's disease: results from a phase 3 clinical trial
    Ghosh, Subrata
    Chen, Minhu
    Fischer, Monika
    Dubinsky, Marla
    Jairath, Vipul
    Hisamatsu, Tadakazu
    Ferrante, Marc
    Peyrin-Biroulet, Laurent
    Siegmund, Britta
    Gibble, Theresa
    Lin, Zhantao
    Protic, Marijana
    Morris, Nathan
    Travis, Simon
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 : S16 - S17
  • [5] MIRIKIZUMAB IMPROVES FATIGUE, BOWEL URGENCY, AND QUALITY OF LIFE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM A PHASE 3 CLINICAL TRIAL
    Ghosh, Subrata
    Chen, Minhu
    Fischer, Monika
    Dubinsky, Marla C.
    Jairath, Vipul
    Hisamatsu, Tadakazu
    Ferrante, Marc
    Peyrin-Biroulet, Laurent
    Siegmund, Britta
    Gibble, Theresa H.
    Lin, Zhantao
    Protic, Marijana
    Morris, Nathan
    Travis, Simon P.
    GASTROENTEROLOGY, 2024, 166 (05) : S850 - S851
  • [6] MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
    Reguiro, Miguel D.
    Fischer, Monika
    Rubin, David T.
    Shan, Mingyang
    Deckard, Deanilee
    Pollack, Paul
    Hunter, Theresa
    Chan, Lai Shan
    Hindryckx, Pieter
    GASTROENTEROLOGY, 2021, 160 (06) : S354 - S355
  • [7] Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study
    Regueiro, Miguel
    Fischer, Monika
    Bossuyt, Peter
    Mcginnis, Kim
    Protic, Marijana
    Hunter Gibble, Theresa
    Panni, Tommaso
    Chan, Lai Shan
    Hibi, Toshifumi
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 432 - 441
  • [8] MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
    Loftus, Edward
    Pollack, Paul
    Hunter, Theresa
    Shan, Mingyang
    Chan, Lai-Shan
    Deckard, Deanilee
    Cross, Raymond
    GASTROENTEROLOGY, 2022, 162 (03) : S15 - S15
  • [9] MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
    Loftus, Edward
    Pollack, Paul
    Hunter, Theresa
    Shan, Mingyang
    Chan, Lai-Shan
    Deckard, Deanilee
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S15 - S15
  • [10] Mirikizumab Sustained Improvement on Fatigue in Patients With Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study at Week 104
    Regueiro, Miguel
    Fischer, Monika
    Bossuyt, Peter
    McGinnis, Kim
    Gibble, Theresa Hunter
    Protic, Marijana
    Panni, Tommaso
    Hibi, Toshifumi
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S816 - S816
12345